Elizabeth Kozora

Elizabeth Kozora

Auto-generated profile, based on publicly available information

Elizabeth Kozora

National Jewish Medical and Research Center, Denver, Colorado 80206, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2006 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
EKElizabeth Kozora
Elizabeth Kozora
MEMisoo C. Ellison
Misoo C. Ellison
SWSterling West
Sterling West

11 October 2004 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
EKElizabeth Kozora
Elizabeth Kozora
MEMisoo C. Ellison
Misoo C. Ellison
SWSterling West
Sterling West

30 October 2008 in Arthritis & Rheumatism
Verified
Journal Article
Closed access
PDF file
EKElizabeth Kozora
Elizabeth Kozora
JHJohn G. Hanly
John G. Hanly
LLLarissa Lapteva
Larissa Lapteva
CFChristopher M. Filley
Christopher M. Filley

1 May 2005 in Lupus
Verified
Journal Article
Closed access
EKE Kozora
E Kozora
MEM C Ellison
M C Ellison
JWJ A Waxmonsky
J A Waxmonsky
FWF S Wamboldt
F S Wamboldt
TPT L Patterson
T L Patterson
The objective of this study was to examine psychological processes in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients in relation to measures of life stress, coping styles, social support and cognitive ability. Fifty-two SLE patients without overt neuropsychiatric symptoms, 29 RA patients and 27 healthy controls completed measures of depression, mood, disease activity, perceived health, stressful life events, coping, and social support. Variables entered into the multiple regression analysis following principal component analysis were: group, major difficult event, major life threatening event, disengaging coping, emotional coping, social support, and cognitive impairment. Depressive symptoms were associated with SLE group status (P, 0.001), major life-threatening events (P, 0.01), disengage coping (P, 0.001) and emotional coping (P, 0.05). SLE group status (P, 0.05), disengage coping (P, 0.05) and emotional coping (P, 0.05) were associated with current distressed mood. SLE patients without overt, major neuropsychiatric symptoms had greater psychological distress compared to RA and control subjects. Increased depressive symptoms and distressed mood state in SLE patients were related to use of disengaging and emotional coping styles. These findings are limited to SLE patients with no overt neuropsychiatric illness and low disease activity, suggesting the need for future studies with a greater variety of SLE patients. Interventions aimed at improving active coping and minimizing emotional response to stress may lower psychological distress in SLE patients with mild disease.

25 September 2001 in Journal of the International Neuropsychological Society
Verified
Journal Article
Closed access
PDF file
EKElizabeth Kozora
Elizabeth Kozora
MLMark Laudenslager
Mark Laudenslager
ALAndrine Lemieux
Andrine Lemieux
SWSterling G. West
Sterling G. West
Abnormalities of inflammatory and hormonal measures are common in SLE patients. Although cognitive dysfunction has been documented in SLE patients, the biological mechanism of these deficits has not been clarified. The goal of this study was to explore the relationship between inflammatory and hormonal activity and measures of learning, fluency, and attention in systemic lupus erythematosus patients without neuropsychiatric symptoms (non-CNS–SLE), patients with rheumatoid arthritis (RA), and healthy controls (HC). Fifteen non-CNS–SLE patients, 15 RA patients and 15 HC participants similar in age, education, and gender (female) were compared on tests of cognition, depression, and plasma levels of interleukin-6 (IL-6), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S) and cortisol. Non-CNS–SLE patients demonstrated lower learning and poorer attention. Furthermore, non-CNS–SLE and RA patients had significantly lower levels of DHEA and DHEA-S than HC participants. Hierarchical regression analysis demonstrates that DHEA-S and IL-6 accounts for a unique portion of the variance in subject performance on measures of learning and attention after controlling for depression and corticosteroid treatment. This data highlights the value of hierarchical analyses with covariates, and provides evidence in humans of a relationship between peripheral cytokine levels and cognitive function. (JINS, 2001, 7, 745–754.)

30 October 2008 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
EKElizabeth Kozora
Elizabeth Kozora
DADavid B. Arciniegas
David B. Arciniegas
CFChristopher M. Filley
Christopher M. Filley
SWSterling G. West
Sterling G. West
MBMark Brown
Mark Brown
LZLening Zhang
Lening Zhang
Objective: To examine neuropsychological and neurologic functioning in systemic lupus erythematosus (SLE) patients without histories of overt neuropsychiatric disorders (non‐NPSLE patients).Methods: Sixty‐seven non‐NPSLE patients and 29 healthy controls were administered a standardized neurologic examination and measures of cognition, depression, and self‐reported cognitive functioning.Results: Non‐NPSLE patients scored lower than controls on the total score of the neurologic examination (P < 0.0001). Item analysis indicated that the physician's description of mentation and mood was the only item that differed significantly between patients with SLE and controls (P = 0.004). Compared with controls, non‐NPSLE patients had significantly higher rates of impairment on logical reasoning (P = 0.012) and verbal memory (P = 0.03), and trends toward greater impairment on visual attention (P = 0.06) and working memory (P = 0.098). There were no significant differences between non‐NPSLE patients and controls on a cognitive impairment index (CII): 20.9% of non‐NPSLE patients and 13.8% of controls were impaired. Patients with SLE scored higher on depressive symptoms (P < 0.0001) and perceived cognitive difficulties (P = 0.001) compared with controls.Conclusion: The utility of a standardized neurologic examination in SLE for excluding overt neurologic dysfunction and assuring a non‐NPSLE group selection was demonstrated. In contrast to our earlier study, we did not find differences between non‐NPSLE patients and controls on the CII. Slightly lower CII scores in non‐NPSLE patients and higher CII scores in controls may have reduced cognitive differences between these groups. Non‐NPSLE patients demonstrate specific decline in the areas of attention, memory, and reasoning; continued studies of associated brain regions are warranted.